Comments on: Aspirin May Reduce the Spread of Breast Cancer http://www.bami.us/wordpress/2010/02/18/aspirin-may-reduce-the-spread-of-breast-cancer/ Information you can trust Sun, 12 Feb 2012 09:43:27 +0000 http://wordpress.org/?v=abc By: Cary http://www.bami.us/wordpress/2010/02/18/aspirin-may-reduce-the-spread-of-breast-cancer/#comment-493 Cary Mon, 12 Apr 2010 12:34:19 +0000 http://www.bami.us/wordpress/?p=306#comment-493 I am totally agree with your oppinion.this blog post is very encouraging to people who want to know these topics. I am totally agree with your oppinion.this blog post is very encouraging to people who want to know these topics.

]]> By: Breast cancer stages http://www.bami.us/wordpress/2010/02/18/aspirin-may-reduce-the-spread-of-breast-cancer/#comment-389 Breast cancer stages Fri, 19 Feb 2010 10:30:12 +0000 http://www.bami.us/wordpress/?p=306#comment-389 Of the total, 196 were taking aspirin, 58 were taking Coumadin, and 24 were on Plavix. The other men weren't taking any anti-clotting medication. About four years after they were treated, cancer recurred in only 9% of men taking an anti-clotting medication, compared with 22% of those who weren't taking the drugs. After taking into account other risk factors for recurrence, taking an anti-clotting medication was associated with a 46% lower risk of recurrence, Choe says. The benefit was most pronounced in men with high-risk aggressive cancers that had not yet spread at the time of radiation treatment. In this group, cancer recurred in 18% of men on anticoagulants vs. 42% of men not taking the drugs. Of the total, 196 were taking aspirin, 58 were taking Coumadin, and 24 were on Plavix. The other men weren’t taking any anti-clotting medication. About four years after they were treated, cancer recurred in only 9% of men taking an anti-clotting medication, compared with 22% of those who weren’t taking the drugs. After taking into account other risk factors for recurrence, taking an anti-clotting medication was associated with a 46% lower risk of recurrence, Choe says.

The benefit was most pronounced in men with high-risk aggressive cancers that had not yet spread at the time of radiation treatment. In this group, cancer recurred in 18% of men on anticoagulants vs. 42% of men not taking the drugs.

]]>